Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$119.87 - $145.67 $325,327 - $395,348
-2,714 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $4.21 Million - $6.05 Million
-32,763 Reduced 92.35%
2,714 $352,000
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $399,218 - $464,558
2,492 Added 7.55%
35,477 $6.3 Million
Q1 2021

May 18, 2021

SELL
$150.19 - $173.5 $1.08 Million - $1.25 Million
-7,215 Reduced 17.95%
32,985 $5.42 Million
Q4 2020

Feb 16, 2021

BUY
$140.71 - $165.05 $708,334 - $830,861
5,034 Added 14.31%
40,200 $6.64 Million
Q3 2020

Nov 16, 2020

BUY
$105.46 - $144.13 $77,724 - $106,223
737 Added 2.14%
35,166 $5.01 Million
Q2 2020

Aug 14, 2020

SELL
$95.68 - $121.88 $8.64 Million - $11 Million
-90,279 Reduced 72.39%
34,429 $3.8 Million
Q4 2019

Feb 12, 2020

BUY
$117.65 - $153.73 $11.9 Million - $15.5 Million
101,015 Added 426.35%
124,708 $18.6 Million
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $34,174 - $39,104
273 Added 1.17%
23,693 $3.04 Million
Q2 2019

Aug 13, 2019

BUY
$125.55 - $144.48 $64,156 - $73,829
511 Added 2.23%
23,420 $3.34 Million
Q1 2019

May 14, 2019

BUY
$121.81 - $142.95 $2.34 Million - $2.75 Million
19,218 Added 520.67%
22,909 $3.27 Million
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $423,412 - $608,934
3,652 Added 9364.1%
3,691 $457,000
Q3 2018

Nov 15, 2018

BUY
$161.01 - $180.57 $4,186 - $4,694
26 Added 200.0%
39 $6,000
Q2 2018

Aug 15, 2018

BUY
$146.33 - $183.18 $1,902 - $2,381
13 New
13 $2,000
Q4 2017

Feb 15, 2018

SELL
$131.06 - $150.39 $1,703 - $1,955
-13 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $1,854 - $2,022
13
13 $0

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.47B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.